Background: Multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) are central nervous system (CNS) inflammatory demyelinating disorders. It is clinically important to distinguish MS from NMOSD, as treatment and prognosis differ. Brainstem involvement is common in both disorders. Purpose: To investigate whether the patterns of brainstem atrophy on volumetric analysis in MS and NMOSD were different and correlated with clinical disability. Study Type: Case-control cross-sectional study. Subjects: In all, 17 MS, 13 NMOSD, and 18 healthy control (HC) subjects were studied. Field Strength/Sequence: T 1 -weighted and T 2 w spin-echo images were acquired with a 3T scanner. Assessment: Semiautomated segmentation and volumetric measurement of brainstem regions were performed. Anatomical information was obtained from whole brain T 1 w images using a 3D magnetization-prepared rapid gradient-echo (MPRAGE) imaging sequence (TR/TE/T: 7.0/3.2/800 msec, voxel size: 1 3 1 3 1 mm 3 , scan time: 10 min 41 sec). Statistical Tests: Independent samples t-test, Mann-Whitney U-test, partial correlation, and multiple regression analysis. Results: Baseline characteristics were similar across the three groups, without significant difference in disease duration (P 5 0.354) and EDSS score (P 5 0.159) between MS and NMOSD subjects. Compared to HC, MS subjects had significantly smaller normalized whole brainstem (25.2%, P 5 0.027), midbrain (28.3%, P 5 0.0001), and pons volumes (25.9%, P 5 0.048), while only the normalized medulla volume was significantly smaller in NMOSD subjects compared to HC (28.5% vs. HC, P 5 0.024). Normalized midbrain volume was significantly smaller in MS compared to NMOSD subjects (25.0%, P 5 0.014), whereas normalized medulla volume was significantly smaller in NMOSD compared to MS subjects (28.1%, P 5 0.032). Partial correlations and multiple regression analysis revealed that smaller normalized whole brainstem, pons, and medulla oblongata volumes were associated with greater disability on the Expanded Disability Status Scale (EDSS), Functional System Score (FSS)-brainstem and FSS-cerebellar in NMOSD subjects. Data Conclusion: Differential patterns of brainstem atrophy were observed, with the midbrain being most severely affected followed by pons in MS, whereas only the medulla oblongata was affected in NMOSD. Level of Evidence: 2 Technical Efficacy: Stage 3
and loss, lymphocytic inflammatory infiltrate, and reactive astrocytes during acute neuroinflammation and chronic demyelination, partial remyelination, axonal and neuronal loss, astrogliosis, and brain and spinal cord atrophy in the chronic phase. 2, 3 Neuromyelitis optica spectrum disorders (NMOSD) belong to another group of CNS IDD. The majority of NMOSD patients have relapsing attacks of neuroinflammation, classically severe unilateral or bilateral optic neuritis, longitudinally extensive myelitis, and less commonly cerebral involvement affecting the dorsal medulla (area postrema), other brainstem regions, peri-ventricular and peri-ependymal regions of the diencephalon, as well as cerebral hemispheres that can mimic MS. 4, 5 However, NMOSD is distinct from MS, as the underlying pathophysiology, autoimmunity against the aquaporin-4 (AQP4) water channel, is present in the majority of NMOSD patients but absent in MS patients. 6 This is evidenced by the detection of autoantibodies against aquaporin-4 (AQP4-IgG) in the serum of the majority of NMOSD (75%), but not in MS patients. 7 Inflammatory infiltrates composed of macrophages, neutrophils, eosinophils, and variable amounts of lymphocytes, demyelination, white and gray matter necrosis, vasculocentric deposition of immunoglobulins, and complement activation products (C9neo) with hyalinized blood vessel walls, loss of AQP4 and astrocytes, cavitation, and cord atrophy are the typical pathologies observed in affected spinal cord of AQP4-IgG-positive NMOSD patients. 8, 9 The prevalence of MS is much higher among Caucasians than Asians, whereas NMOSDs are more prevalent among Asians, including Hong Kong Chinese, than Caucasians. Our recent single-center study revealed that MS and NMOSD account for 41.9% and 22.4% of CNS IDD in our patients, respectively, suggesting that MS and NMOSD are the two most common CNS IDD in Hong Kong Chinese. 10 The distinction of MS from NMOSD is important, as long-term disease-modifying therapies (DMTs) for MS such as interferon-b, fingolimod, and natalizumab may be ineffective and even harmful for NMOSD. [11] [12] [13] Early diagnosis of NMOSD confirmed with detection of AQP4-IgG is critically important, as prompt initiation of immunosuppressive therapy is indicated to prevent relapses, which are typically severe, disabling, and even life-threatening.
9,14
The brainstem is frequently affected, both clinically and radiologically, in both MS and NMOSD patients. 15, 16 We hypothesized that the brainstem volume is significantly reduced in our MS and NMOSD patients, and the pattern of volume loss is different between MS and NMOSD, as the medulla seems more commonly and severely affected in NMOSD. In this study, we aimed to measure the brainstem volume at the midbrain, pons, and medulla level in a cohort of Chinese MS and NMOSD patients, and analyze whether the regional brainstem volumes correlate with neurological disability scores of the patients, which may help to understand the differences in patterns of neurological disability.
Subjects and Methods

Recruitment of Subjects
Magnetic resonance imaging (MRI) of 17 RRMS patients, 13 NMOSD patients, and 18 healthy control (HC) subjects were investigated. Diagnoses of MS and NMOSD were made according to the 2010 revisions to the McDonald Criteria of the International Panel on Diagnosis of MS 17 and 2006 revised diagnostic criteria for neuromyelitis optica, 18 respectively. All the NMOSD subjects included also fulfilled the recently revised diagnostic criteria. 6 None of the HC subjects had a neurological or psychological condition, physical disability, or abnormality on brain MR images. Neurologic disabilities of the MS and NMOSD subjects were assessed by a neurologist (K.H.C.) at the time of the MR scan, and graded according to Kurtzke Functional System Scores (FSS) and the Expanded Disability Status Scale (EDSS). This study was approved by the local Institutional Review Board. Informed consents were obtained from all participants.
MRI Acquisition
Imaging was performed on a 3T scanner (Achieva, Philips Healthcare, Best, The Netherlands) with a body coil for excitation and an 8-channel head coil for reception. Anatomical information was obtained from whole brain T 1 -weighted (T 1 w) images acquired using 3D a magnetization-prepared rapid gradient-echo (MPRAGE) imaging sequence (TR/TE/T: 7.0/3.2/800 msec, voxel size: 1 3 1 3 1 mm 3 , scan time: 10 min 41 sec). Additionally, T 2 -weighted (T 2 w) spin-echo images were acquired (44 axial slices with no interslice gap, slice thickness: 3 mm, in-plane resolution: 1 3 1 mm). Both T 1 w and T 2 w images were examined to exclude pathology other than MS or NMOSD by a neuroradiologist (H.K.M.) with 24 years of experience in clinical work and research in neuroradiology.
Image Processing and Volumetric Analysis
The T 1 w-MPRAGE images were first processed with the automatic structural imaging processing stream 19 in Freesurfer v. 5.3.0. 20 Cerebellar volumes were generated by the standard Freesurfer processing pipeline. Brainstem segmentation was then refined with the brainstem substructures tools. 21 Visual checking and manual corrective voxel-editing of the brainstem segmentations were then performed by a neurologist (C.Y.L.) with experience in neuroimaging processing. Volumes of the brainstem structures were computed based on these corrected segmentations.
To account for differences in brain sizes attributable to variation in head size, [22] [23] [24] all volumes were adjusted for head size variation. Total intracranial volume (TICV) was estimated using SPM12 (http://www.fil.ion.ucl.ac.uk/spm/software/spm12) with its "Segment" and "Tissue Volumes" utilities. 25 Hyperintense lesions on T 2 w images were manually outlined by a neurologist (C.Y.L.) with experience in neuroimaging processing and T 2 lesion volume (T 2 LV) was then calculated using MIPAV 26 ; this was repeated by a neuroradiologist (H.C.C.) with experience in neuroimaging processes which yielded an interobserver Pearson correlation coefficient of 0.911 (P 5 0.000) with measurement by the neurologist, indicating high interobserver consistency
Data and Statistical Analysis
All statistical analyses were performed with SPSS v. 23 (Chicago, IL). The volume estimates computed were normalized to the TICV using the residual method. 23 The residual method predicts a normalized volume according to the correlation between the computed volume estimates and the TICV using the following equation:
Both TICV [mean] and the coefficient a are calculated from the HC subjects; a is the gradient of the ordinary least-squares regression line between the computed volumes and TICV. A distinct a value was estimated for midbrain, pons, medulla oblongata, whole brainstem, cerebellum, and whole brain correspondingly. b Seven out of 13 of the NMO subjects had supratentorial lesions (range 0.07-1.4ml) and only 1 out of 13 had infratentorial lesions of 0.39ml. * P < 0.05, ** P < 0.01, *** P < 0.001 for comparison between MS and NMOSD subjects. † P < 0.05, † † P < 0.01, † † † P < 0.001 for comparison between MS and control subjects. # P < 0.05 for comparison between NMOSD and control subjects.
Lesion volumes were also normalized according to individual head and brain size. Different volumes of interest (VOIs) and other normally distributed continuous variables between groups were compared using independent samples t-test, while nonnormally distributed or ordinal variables were compared using a Mann-Whitney U-test. Partial correlation was employed to assess associations between VOIs, different clinical scores, and other continuous variables with correction for age and sex. To find the predictive factors and models for EDSS and FSS, variables (VOIs or other clinical parameters) with P < 0.1 in univariate analysis were further analyzed using multiple regression with backward selection method and adjustment of age and sex. VOIs with high collinearity, eg, brainstem volume and pons volume were tested in separate regression models. A P-value (two-tailed) less than 0.05 was considered statistically significant. The significant predictive models were compared based on the adjusted squared multiple correlation coefficients (R 2 ) and those with highest R 2 are presented as the final models.
Results
Baseline Characteristics
The demographic, clinical, and MRI characteristics of the subjects are summarized in Table 1 . All the VOIs showed a significant linear relationship with TICV in the control group and were normalized accordingly. Comparing MS and NMOSD subjects, there was no significant difference in disease duration, history of use of immunotherapies, EDSS, FSS-cerebellar, or FSS-brainstem.
Brain and Brainstem Atrophy
The comparative patterns of brainstem atrophy among the three groups are summarized in Table 2 .
MS VS. CONTROLS. The normalized volumes of whole brainstem, midbrain, and pons were significantly reduced in MS subjects compared to HC. The differences were 1.27 mL (5.2%, P 5 0.027), 0.50 mL (8.3%, P 5 0.000), and 0.83 mL (5.9%, P 5 0.048), respectively. The normalized brain volume (NBV), normalized supratentorial brain volume (NStBV), and WM volume were also significantly smaller in MS subjects compared to HC, with a mean difference of 85.35 mL (7.6%, P 5 0.005), 85.97 mL (8.8%, P 5 0.004), and 56.93 mL (13.4%, P < 0.0001), respectively. There was no significant difference in age, gender, normalized volume of medulla oblongata, cerebellum, or TICV.
NMOSD VS. CONTROLS. The normalized volume of medulla oblongata was reduced in the NMOSD group compared to HC with a mean difference of 0.37 mL (8.5%, P 5 0.024). Otherwise, there was no statistically significant difference in whole brain or other VOIs. There was also no significant difference in age, gender, or TICV.
MS VS. NMOSD. MS subjects had smaller midbrain volumes, with a mean difference of 0.29 mL (5.0%, P 5 0.014), and NMO subjects had smaller medulla oblongata volumes, with a mean difference of 0.35 mL (8.1%, P 5 0.032). Figure 2 shows a comparison of MR images of an RRMS subject and an NMOSD subject. The NBV, NStBV, and WM volume were reduced in MS subjects, with a mean difference compared to NMOSD of 80.06 mL (7.2%, P 5 0.009), 78.39 mL (8.1%, P 5 0.009), and 45.56 mL (11.0%, P 5 0.004), respectively. Total, cerebral, and infratentorial T 2 LV were significantly larger in MS. The volumes of pons, whole brainstem, cerebellum, and GM showed no significant difference. There was also no significant difference in age, gender, or TICV. Figure 1 shows T 1 w images with brainstem segmentation of an MS subject and an NMO subject.
MS and NMOSD Subgroup Analysis
In MS subjects (Table 3) , the normalized brainstem volume (NBsV) showed a moderate to strong positive correlation with NStBV (r 5 0.628, P 5 0.027).
No statistically significant correlation was found of EDSS with whole brain volume or T 2 LV (total, cerebral or infratentorial). On the other hand, longer disease duration was associated with higher EDSS (r 5 0.567, P 5 0.028), while smaller NBsV (r 5 -0.461, P 5 0.084), smaller normalized midbrain volume (r 5 -0.444, P 5 0.097), and the use of DMTs (median EDSS 2.75 vs. 1.0, P 5 0.082) showed a trend towards higher EDSS. Multiple regression analysis using age, sex, disease duration, use of DMTs, and NBsV or midbrain volume was performed attempting to predict the EDSS, but a statistically significant model could not be found. For FSS-cerebellar in MS subjects, the only variable with significant correlation was normalized whole brain volume (r 5 -0.603, P 5 0.017) and multiple regression analysis revealed a significant predictive model (adjusted R 2 5 0.480, P 5 0.032) ( Table 4) . No significant association was found between FSS-brainstem and other tested variables. Similar partial correlation analyses were performed in NMOSD subjects (Table 5 ). Larger infratentorial T 2 LV was associated with smaller NBsV and normalized pons volume. Disease duration or AQP4 IgG positivity had no significant association with EDSS or FSS. Multiple regression analysis was performed and the significant predictive models for the clinical disability scores are summarized in Table 6 . NBsV significantly predicted all three clinical scores, while normalized medulla oblongata volume and normalized pons volume predicted FSS-brainstem and FSS-cerebellar.
Discussion
Brainstem involvement is a major cause of significant disability in MS and NMOSD. Our previous study of Chinese RRMS and NMOSD patients revealed that the brainstem is commonly affected in both RRMS (two-thirds) and NMOSD (44%) patients. 15, 16 It is noteworthy that the frequency of brainstem T 2 w hyperintense lesions detected in the current study is much lower than our previous study, because all of these patients have been aggressively treated with immunotherapies and some lesions had resolved. Although more than half of our patients had cerebral lesions detected on MRI, the lesion volumes were small. It is increasingly recognized that brainstem lesions on MRI are common in NMOSD patients. 5, 27 One study from China suggested medulla oblongata lesions as a predictor of more severe neurologic deficits and worse prognosis in NMOSD. 28 Other studies reported whole brain, white matter, focal cortical, and deep gray matter atrophy in NMOSD patients compared to HC, [29] [30] [31] but no consistent pattern was found. Our study showed that medulla oblongata volume was significantly reduced in NMOSD subjects compared to both HC and RRMS subjects, even though our NMOSD patients had relatively short disease duration. Importantly, smaller medulla oblongata volume was associated with more severe brainstem and cerebellar symptoms. There was no significant atrophy compared to HC in gray or white NMOSD 5 neuromyelitis optica spectrum disorder; WB 5 whole brain; Cb 5 cerebellum; NStBV 5 normalized supratentorial brain volume; T2LV 5 T2 lesion volume; EDSS 5 expanded disability status scale; FSS 5 functional system score; NS 5 not significant. P < 0.1, * P < 0.05, ** P < 0.01. matter, supratentorial, or other brainstem regions. Therefore, our findings suggested the importance of medulla volume as an independent marker of disease severity and disability in NMOSD patients, even when brainstem lesions are absent on conventional MRI (after treatment). Studies on brainstem atrophy in MS are limited. Previous studies mainly examined the whole brainstem volume, and consistently reported reduced brainstem volume in MS patients compared to HC. 32, 33 One study that included both RRMS and SPMS patients with a median disease duration of 7 years reported a reduction of brainstem volume of up to 20.6% and brainstem atrophy was associated with higher EDSS score but not supratentorial volume loss. 32 A more recent study showed a 5.2% NBsV reduction in RRMS compared to HC, which was similar to our finding, despite a longer mean disease duration of about 19 years. 33 The authors reported no significant association between NBsV and different clinical measures of motor dysfunction including EDSS in the regression models. 33 Our study extends those findings by identifying that midbrain volume is reduced most (8.3%) followed by pons volume (5.9%) in RRMS patients relative to HC. This is consistent with a recent study of RRMS patients with median disease duration of 9 years using cross-sectional area (CSA) as a measurement reflective of regional brainstem size, which reported a similar descending trend of atrophy from midbrain to medulla. 34 Statistically significant medulla atrophy was not detected in MS patients compared to HC in our study. This may be due to our small sample size and relatively short disease duration of studied subjects. Liptak et al reported that medulla oblongata volume is associated with disability and spinal cord damage in a cohort of MS patients (71% RRMS) with a mean disease duration of 7.1 years, 35 supporting that medulla atrophy is an important pathology in MS. Brain atrophy and lesion load on MRI are important biomarkers in MS 36, 37 and are shown to associate with long-term disabilities. Our findings showed that whole brain and regional (supratentorial, whole brainstem, midbrain, and pons) atrophy were evident in MS subjects, and normalized brainstem volume was positively correlated with supratentorial brain volume. This, together with the descending trend of atrophy from midbrain to medulla, may suggest that brainstem atrophy in MS results from both axonal loss due to Wallerian degeneration of long fiber tracts secondary to cerebral hemispheric lesions and direct axonal injury from brainstem inflammation. No statistically significant association was noted between EDSS and brain volume or T 2 LV in our study, which could be again related to the small sample size. The pathogenetic basis of the observed medulla atrophy in NMOSD patients are uncertain. The area postrema in the dorsal medulla is of particular interest in NMOSD, as the lack of an intact blood-brain barrier in the area postrema allows access of AQP4 IgG in peripheral blood to the CNS in this region. This is consistent with the clinical observation of area postrema syndrome characterized by refractory nausea, hiccups, and/or vomiting in NMOSD patients. Among 15 NMO patients studied, the Mayo investigators found unilateral or bilateral lesions in the medullary floor of the fourth ventricle and area postrema of six patients (40%).
27 AQP4 loss was prominent in lesions of all six patients and the AQP4 loss areas showed tissue rarefaction or vacuolation, blood vessel wall thickening, and marked parenchymal and perivascular infiltration by T cells (CD3 1 and CD81) , B cells, and plasma cells, prominent activation of parenchymal microglia and perivascular macrophages, and prominent astroglial reaction. Complement deposition was observed in three patients but there was no astrocyte loss or acute neuronal pathology in all six patients. 27 We believe that axonal loss complicating repeated attacks of neuroinflammation due to reactive astrocytosis triggered upon AQP4-IgG binding to astrocytic membrane AQP4 may be the pathophysiological basis of medulla atrophy in NMOSD. The common involvement of the medulla oblongata in Asian NMOSD subjects may possibly be due to a high permeability of the blood-brain barrier in the medulla of Asians, and hence increased accessibility to AQP4-IgG, or a high level of AQP4 expression in the medulla of Asians. While the symptoms and clinical presentation of relapses can be similar in MS and NMOSD, their disease course, treatment strategies, and prognosis are markedly different. Along with detection of AQP4-IgG, other clinical and paraclinical features including MRI can be used to differentiate the two. 38 Apart from conventional MRI, other advanced MRI techniques have been employed to study the differences of the two diseases. 39 However, these modalities are largely for research purposes. Our study has shown a differential pattern of atrophy in MS and NMOSD subjects with similar EDSS levels, specifically in the brainstem. Furthermore, our findings were consistent with other studies reporting that MS subjects have more prominent whole brain, supratentorial, and white matter atrophy, and higher T 2 LV (both supratentorial and infratentorial) compared to NMOSD subjects. These regional volume changes reflect different underlying pathophysiological mechanisms and pathologies. Our study has several limitations. First, our sample size was small. Some of the findings and regression models cannot be ascertained with statistical significance. Second, our imaging protocol did not include a fluid attenuated inversion recovery (FLAIR) or proton density (PD)-weighted sequence, and therefore the T 2 LV, which was manually delineated, could subject to intra-and interobserver differences. We suggest in future volumetric studies that a FLAIR sequence should be performed for reproducible measurement of T 2 LV. Third, our study design and imaging protocol did not include measurement of mean upper cervical cord area (MUCCA), which has been reported to be an important predictor of motor dysfunction and disability in MS subjects. 33, 40 We also suggest the addition of other MSspecific functional scores such as the Multiple Sclerosis Functional Composite, which may measure the degree of disability better.
In conclusion, a different pattern of brainstem atrophy was found between RRMS and NMOSD subjects with similar disease duration, functional and disability status. We postulate that these patterns reflect different pathophysiological mechanisms and pathologies underlying the two diseases. Although volumetric measurement of brainstem structures is mainly used in research at present, its value as a biomarker for diagnosis and disease progression in MS and NMOSD deserve clarification by longitudinal studies.
